112 related articles for article (PubMed ID: 7024090)
1. Evidence concerning insulin activity from the structure of a cross-linked derivative.
Cutfield J; Cutfield S; Dodson E; Dodson G; Hodgkin D; Reynolds C
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):755-61. PubMed ID: 7024090
[TBL] [Abstract][Full Text] [Related]
2. Cross-linked [DAlaA1]Insulins. Evidence for a change in the conformation of the insulin monomer at its receptor.
Saunders D; Freude K
Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):655-9. PubMed ID: 7049891
[TBL] [Abstract][Full Text] [Related]
3. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29.
Nakagawa SH; Tager HS
J Biol Chem; 1989 Jan; 264(1):272-9. PubMed ID: 2642474
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the dynamics of crosslinked insulin.
Krüger P; Hahnen J; Wollmer A
Eur Biophys J; 1994; 23(3):177-87. PubMed ID: 7956978
[TBL] [Abstract][Full Text] [Related]
5. BpaB25 insulins. Photoactivatable analogues that quantitatively cross-link, radiolabel, and activate the insulin receptor.
Shoelson SE; Lee J; Lynch CS; Backer JM; Pilch PF
J Biol Chem; 1993 Feb; 268(6):4085-91. PubMed ID: 8382690
[TBL] [Abstract][Full Text] [Related]
6. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin.
De Meyts P; Van Obberghen E; Roth J
Nature; 1978 Jun; 273(5663):504-9. PubMed ID: 661960
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the subunit structure of insulin receptor and its competence to bind insulin and undergo phosphorylation.
Pang DT; Lewis SD; Sharma BR; Shafer JA
Arch Biochem Biophys; 1984 Nov; 234(2):629-38. PubMed ID: 6388504
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
[TBL] [Abstract][Full Text] [Related]
10. Preparation and properties of covalently linked insulin dimers.
Schüttler A; Brandenburg D
Hoppe Seylers Z Physiol Chem; 1982 Mar; 363(3):317-30. PubMed ID: 7042509
[TBL] [Abstract][Full Text] [Related]
11. X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue.
Derewenda U; Derewenda Z; Dodson EJ; Dodson GG; Bing X; Markussen J
J Mol Biol; 1991 Jul; 220(2):425-33. PubMed ID: 1856866
[TBL] [Abstract][Full Text] [Related]
12. Binding of insulin to bovine liver plasma membrane. Use of insulin analogues modified at the A1 residue.
Rösen P; Simon M; Reinauer H
Biochem J; 1980 Mar; 186(3):945-52. PubMed ID: 6994716
[TBL] [Abstract][Full Text] [Related]
13. The biological potency of covalent insulin-receptor complexes. Dependence on site of cross-linkage.
Klotz G; Saunders DJ; Brandenburg D
Hoppe Seylers Z Physiol Chem; 1984 Apr; 365(4):493-8. PubMed ID: 6376321
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting human insulins.
Whittingham JL; Jonassen I; Havelund S; Roberts SM; Dodson EJ; Verma CS; Wilkinson AJ; Dodson GG
Biochemistry; 2004 May; 43(20):5987-95. PubMed ID: 15147182
[TBL] [Abstract][Full Text] [Related]
15. Insulin analogues with modifications in the beta-turn of the B-chain.
Wang SH; Hu SQ; Burke GT; Katsoyannis PG
J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
[TBL] [Abstract][Full Text] [Related]
16. Evidence concerning the mechanism of insulin-receptor interaction and the structure of the insulin receptor from biological properties of covalently linked insulin dimers.
Tatnell MA; Jones RH; Willey KP; Schüttler A; Brandenburg D
Biochem J; 1983 Dec; 216(3):687-94. PubMed ID: 6365079
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding.
Glidden MD; Yang Y; Smith NA; Phillips NB; Carr K; Wickramasinghe NP; Ismail-Beigi F; Lawrence MC; Smith BJ; Weiss MA
J Biol Chem; 2018 Jan; 293(1):69-88. PubMed ID: 29114034
[TBL] [Abstract][Full Text] [Related]
18. Steric requirements at position B12 for high biological activity in insulin.
Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of covalently dimerized insulin derivatives: correlation of partial agonist efficacy with cross-linkage at lysine B29.
Deppe C; Breiner M; Brandenburg D; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):213-7. PubMed ID: 7990980
[TBL] [Abstract][Full Text] [Related]
20. The relation of polypeptide hormone structure and flexibility to receptor binding: the relevance of X-ray studies on insulins, glucagon and human placental lactogen.
Pullen RA; Jenkins JA; Tickle IJ; Wood SP; Blundell TL
Mol Cell Biochem; 1975 Jul; 8(1):5-20. PubMed ID: 170505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
